Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × nintedanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 5 Carcinoma, Hepatocellular 3 Radiation Pneumonitis 2 Peritoneal Neoplasms 2 Neoplasms 2 Colorectal Neoplasms 2 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Oligodendroglioma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophagogastric Adenocarcinoma 1 Endometrial Adenocarcinoma 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Appendiceal Neoplasms 1

Interventions

vandetanib 7 lenvatinib 5 cabozantinib 4 Sunitinib 4 Sorafenib 4 AZD 6244 3 selpercatinib 2 durvalumab 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Paclitaxel 2 Iodine-131 2 Everolimus 2 Bortezomib 2 Axitinib 2 tremelimumab 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 regorafenib 1 pralsetinib 1 ponatinib 1 perflutren 1 pazopanib 1 pasireotide 1 methyl N-acetylsibirosaminide 1 gallium 68 PSMA-11 1 fosbretabulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡